MFDS Begins Review for Approval of GC Green Cross COVID-19 Treatment (Update)
![[Image source=Yonhap News]](http://www.asiae.co.kr/news/img_view.htm?img=2020080115344492125_1596263684.jpg)
[Asia Economy Reporter Seo So-jeong] The Ministry of Food and Drug Safety (Minister Kim Gang-rip) announced on the 30th that GC Green Cross has applied for marketing authorization for 'Zicoviddic Injection,' developed as a COVID-19 treatment.
Zicoviddic Injection is a plasma fraction therapy made by concentrating antibodies at high levels from the blood of patients recovering from COVID-19 infection.
The Ministry of Food and Drug Safety plans to thoroughly review the submitted quality, clinical, and Good Manufacturing Practice (GMP) data, and after consulting external experts, will rigorously verify the submitted materials to decide on the approval.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- [Tomorrow's Weather] Rain Across the Country Brings Relief from Heat...Caution Advised for Strong Winds
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
The Ministry stated, "In the approval review process for COVID-19 treatments and vaccines, we will thoroughly verify safety and efficacy, and strive to conduct the approval and review process with professionalism and objectivity."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
